| Literature DB >> 29386131 |
Weiwei Dai1, Yoshiko Usami1, Yuanfei Wu1, Heinrich Göttlinger2.
Abstract
We recently identified the multipass transmembrane protein SERINC5 as an antiviral protein that can potently inhibit HIV-1 infectivity and is counteracted by HIV-1 Nef. We now report that the anti-HIV-1 activity, but not the sensitivity to Nef, is conserved among vertebrate SERINC5 proteins. However, a Nef-resistant SERINC5 became Nef sensitive when its intracellular loop 4 (ICL4) was replaced by that of Nef-sensitive human SERINC5. Conversely, human SERINC5 became resistant to Nef when its ICL4 was replaced by that of a Nef-resistant SERINC5. In general, ICL4 regions from SERINCs that exhibited resistance to a given Nef conferred resistance to the same Nef when transferred to a sensitive SERINC, and vice versa. Our results establish that human SERINC5 can be modified to restrict HIV-1 infectivity even in the presence of Nef.Entities:
Keywords: HIV-1; Nef; SERINC5; restriction factor
Mesh:
Substances:
Year: 2018 PMID: 29386131 PMCID: PMC5810964 DOI: 10.1016/j.celrep.2017.12.082
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423